edotreotide has been researched along with actinium in 4 studies
| Studies (edotreotide) | Trials (edotreotide) | Recent Studies (post-2010) (edotreotide) | Studies (actinium) | Trials (actinium) | Recent Studies (post-2010) (actinium) |
|---|---|---|---|---|---|
| 206 | 34 | 86 | 240 | 1 | 142 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, T; Atcher, R; Nayak, T; Norenberg, J | 1 |
| Baum, RP; Kulkarni, HR; Zhang, J | 2 |
| Bokhari, TH; Hassan, M; Khosa, MK; Lodhi, NA; Usman, M | 1 |
1 review(s) available for edotreotide and actinium
| Article | Year |
|---|---|
A review of recent advancements in Actinium-225 labeled compounds and biomolecules for therapeutic purposes.
Topics: Actinium; Humans; Male; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals | 2023 |
3 other study(ies) available for edotreotide and actinium
| Article | Year |
|---|---|
A comparison of high- versus low-linear energy transfer somatostatin receptor targeted radionuclide therapy in vitro.
Topics: Actinium; Alpha Particles; Apoptosis; Beta Particles; Bismuth; Cell Line, Tumor; Cell Nucleus; Cell Survival; Dose-Response Relationship, Radiation; Energy Transfer; Enzyme-Linked Immunosorbent Assay; Humans; Ligands; Lutetium; Mitosis; Models, Statistical; Neoplasms; Octreotide; Radioisotopes; Radiometry; Radiopharmaceuticals; Receptors, Somatostatin | 2005 |
Peptide Receptor Radionuclide Therapy Using 225Ac-DOTATOC Achieves Partial Remission in a Patient With Progressive Neuroendocrine Liver Metastases After Repeated β-Emitter Peptide Receptor Radionuclide Therapy.
Topics: Actinium; Aged; Beta Particles; Disease Progression; Female; Humans; Liver Neoplasms; Neuroendocrine Tumors; Octreotide; Receptors, Peptide; Treatment Outcome | 2020 |
225Ac-DOTATOC-Targeted Somatostatin Receptor α-Therapy in a Patient With Metastatic Neuroendocrine Tumor of the Thymus, Refractory to β-Radiation.
Topics: Actinium; Humans; Neuroendocrine Tumors; Octreotide; Receptors, Somatostatin; Yttrium Radioisotopes | 2021 |